Publication

The Pox in the North American Backyard: Volepox Virus Pathogenesis in California Mice (Peromyscus californicus)

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Nadia F. Gallardo-Romero, Centers for Disease Control and PreventionClifton P. Drew, Centers for Disease Control and PreventionSonja L. Weiss, Centers for Disease Control and PreventionMaureen G. Metcalfe, Centers for Disease Control and PreventionYoshinori J. Nakazawa, Centers for Disease Control and PreventionScott K. Smith, Centers for Disease Control and PreventionGinny L. Emerson, Centers for Disease Control and PreventionChristina L. Hutson, Centers for Disease Control and PreventionJohanna S. Salzer, Centers for Disease Control and PreventionJeanine H. Bartlett, Centers for Disease Control and PreventionVictoria A. Olson, Centers for Disease Control and PreventionCody J. Clemmons, Centers for Disease Control and PreventionWhitni B. Davidson, Centers for Disease Control and PreventionSherif Zaki, Emory UniversityKevin L. Karem, Centers for Disease Control and PreventionInger Damon, Emory UniversityDarin S. Carroll, Centers for Disease Control and Prevention
Language
  • English
Date
  • 2012-08-28
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • © 2012.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1932-6203
Volume
  • 7
Issue
  • 8
Start Page
  • e43881
End Page
  • e43881
Grant/Funding Information
  • The authors have no support or funding to report.
Abstract
  • Volepox virus (VPXV) was first isolated in 1985 from a hind foot scab of an otherwise healthy California vole (Microtus californicus). Subsequent surveys in San Mateo County, CA, revealed serological evidence suggesting that VPXV is endemic to this area, and a second viral isolate from a Pinyon mouse (Peromyscus truei) was collected in 1988. Since then, few studies have been conducted regarding the ecology, pathology, and pathogenicity of VPXV, and its prevalence and role as a potential zoonotic agent remain unknown. To increase our understanding of VPXV disease progression, we challenged 24 California mice (Peromyscus californicus) intranasally with 1.6×103 PFU of purified VPXV. By day five post infection (pi) we observed decreased activity level, conjunctivitis, ruffled hair, skin lesions, facial edema, and crusty noses. A mortality rate of 54% was noted by day eight pi. In addition, internal organ necrosis and hemorrhages were observed during necropsy of deceased or euthanized animals. Viral loads in tissues (brain, gonad, kidney, liver, lung, spleen, submandibular lymph node, and adrenal gland), bodily secretions (saliva, and tears), and excretions (urine, and/or feces) were evaluated and compared using real time-PCR and tissue culture. Viral loads measured as high as 2×109 PFU/mL in some organs. Our results suggest that VPXV can cause extreme morbidity and mortality within rodent populations sympatric with the known VPXV reservoirs.
Author Notes
Keywords
Research Categories
  • Biology, Animal Physiology
  • Biology, Microbiology

Tools

Relations

In Collection:

Items